XML 80 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 10 - Equity-based Compensation - Summary of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Outstanding, Number (in shares) 46,087,641    
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 5.9    
Outstanding, Weighted Average Remaining Contractual Term (Year) 5 years 3 months 25 days 5 years 3 months 25 days  
Outstanding, Intrinsic Value $ 63 $ 0  
Granted, Number (in shares) 11,873,258    
Granted, Weighted Average Exercise Price (in dollars per share) $ 1.6    
Exercised, Number (in shares) (18,750) (211,187) (445,437)
Exercised, Weighted Average Exercise Price (in dollars per share) $ 2.12    
Forfeited, Number (in shares) (886,007)   0
Forfeited, Weighted Average Exercise Price (in dollars per share) $ 3.13    
Expired, Number (in shares) (5,199,136)    
Expired, Weighted Average Exercise Price (in dollars per share) $ 6.18    
Outstanding, Number (in shares) 51,857,006 46,087,641  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 4.94 $ 5.9  
Vested and expected to vest, Number (in shares) 51,857,006    
Vested and expected to vest, Weighted Average Exercise Price (in dollars per share) $ 4.94    
Vested and expected to vest, Weighted Average Remaining Contractual Term (Year) 5 years 3 months 25 days    
Vested and expected to vest, Intrinsic Value $ 63    
Exercisable, Number (in shares) 33,681,791    
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 6.34    
Exercisable, Weighted Average Remaining Contractual Term (Year) 3 years 9 months 18 days    
Exercisable, Intrinsic Value $ 63